Cancer Therapy News and Research

RSS

Breakthrough in cancer research can help reduce heart failure, increase survival rates

A breakthrough by scientists at Queen's University Belfast could help reduce heart failure in cancer patients around the world, and ultimately increase survival rates.

10 Feb 2011

NYBC ends emergency appeal for blood donations

Thanks to the support of blood donors – who answered the emergency call after winter snowstorms drove blood supplies to critical levels – New York Blood Center is ending its emergency appeal for blood donations and returning to its normal collection schedule. The supply of several blood types, including O-negative blood, has returned to recommended 3-5 day inventory levels.

10 Feb 2011

CeNeRx announces FDA approval of CXB909 IND for neuroprotection and neurodegenerative disorders

CeNeRx BioPharma, Inc., a clinical-stage company developing and commercializing innovative treatments for diseases of the central nervous system (CNS), today announced FDA approval of its IND and reported the first clinical results in humans for CXB909, a novel agent that has demonstrated utility in preclinical models of neuroprotection and neurodegenerative disorders.

9 Feb 2011

Men with high levels of CCP genes more likely to have fatal form of prostate cancer

A genetic pattern could predict how aggressive prostate cancer is before treatment, and whether the disease will come back in men who have already been treated, according to research published1 in the Lancet Oncology.

9 Feb 2011

Tower announces formation of Cancer Support Network to provide high quality of care

As part of its commitment to providing the highest quality of care to the community, Tower Hematology Oncology Medical Group has announced the formation of Tower Oncology's Cancer Support Network.

8 Feb 2011

Genomic study identifies link between Native American ancestry, relapse in young leukemia patients

The first genome-wide study to demonstrate an inherited genetic basis for racial and ethnic disparities in cancer survival linked Native American ancestry with an increased risk of relapse in young leukemia patients. The work was done by investigators at St. Jude Children's Research Hospital and the Children's Oncology Group.

6 Feb 2011

Patients receiving cancer treatment may experience skin, hair, nail problems

A cancer diagnosis and subsequent treatment, which commonly includes chemotherapy or radiation, can be taxing physically and emotionally on any patient. If that is not enough, dermatologists are cautioning patients receiving cancer treatment and cancer survivors that they may experience a host of skin, hair or nail problems as a direct result of their therapy that may require additional treatment by a dermatologist.

5 Feb 2011

EpiCareSRT, Sensus Healthcare aim for mobile non-surgical skin cancer treatment service

EpiCareSRT announced today it has entered into a strategic partnership with Sensus Healthcare to take new aim at skin cancer by providing the first mobile service to bring low-dose superficial radiation therapy directly to the point-of-care in dermatology offices.

5 Feb 2011

Surrogate questions imaging can answer about cancer

A Professor who is investigating how modern body imaging techniques can be adapted to answer new questions - such as the anti-cancer properties of fish oils and green tea, or establishing cause of death in forensic investigation - is to give a free public lecture at the University of Leicester.

3 Feb 2011

PanCare Childhood and Adolescent Cancer Survivor Care and Follow-up Studies to kick off in Lund, Sweden

By learning more about these late effects of treatment, the health care services can, on the one hand, improve and reduce the intensity of the treatment, and, on the other hand, find appropriate ways to care for those suffering from side-effects of the treatment in adolescence and adulthood.

3 Feb 2011

Losartan improves effectiveness of nanotherapeutics against cancer

Low doses of an inexpensive, FDA-approved hypertension medication may improve the results of nanotherapeutic approaches to cancer treatment. In a report in the early edition of Proceedings of the National Academy of Sciences, Massachusetts General Hospital (MGH) investigators describe experiments showing that the generic drug losartan, by modifying the network of collagen fibers that characterizes most solid tumors, improved the effectiveness of two nanotherapeutics against several types of cancer.

3 Feb 2011

Four-gene/protein signature more accurately predicts metastatic prostate cancer

Prostate tumors that carry a "signature" of four molecular markers have the potential to become dangerously metastatic if not treated aggressively, researchers at Dana-Farber Cancer Institute report in a study published online today by the journal Nature. The discovery lays the groundwork for the first gene-based test for determining whether a man's prostate cancer is likely to remain dormant within the prostate gland, or spread lethally to other parts of the body.

3 Feb 2011

Aphios enters subcontract with SAIC-Frederick to develop phospholipid nanoencapsulated camptothecin

Aphios® Corporation today announced that it has entered into a subcontract with SAIC-Frederick, a subsidiary of Science Applications International Corporation, to develop phospholipid nanoencapsulated camptothecin, Camposomes™, for the treatment of pancreatic and other cancers, supporting the NCI Alliance for Nanotechnology.

2 Feb 2011

$Researchers find breast cancer therapy contributes to early-in-life hip fractures in women$

Researchers find breast cancer therapy contributes to early-in-life hip fractures in women

A hip fracture is not common in a 54-year-old woman, unless she is a 54-year-old breast cancer survivor, according to a new Northwestern Medicine study. Researchers found that a combination of early menopause due to breast cancer treatment and common drugs used to treat breast cancer, could be weakening the bones of breast cancer survivors once they hit middle age, leading to hip fractures.

2 Feb 2011

New robotic technique can better predict tumors during radiotherapy, prevent severity of side effects

Medical physicists at Thomas Jefferson University and Jefferson's Kimmel Cancer Center have demonstrated a new real-time tumor tracking technique that can help minimize the amount of radiation delivered to surrounding healthy tissue in a patient—up to 50 percent less in some cases—and maximize the dose the tumor receives.

2 Feb 2011

Fox Chase announces posting of clinical outcomes data to its website for patient use

Fox Chase Cancer Center, one of the nation's leading cancer research and treatment institutions, today announced the posting of clinical outcomes data to its website as a tool to assist newly-diagnosed patients in deciding where to seek cancer care.

1 Feb 2011

FDA approves ultrasmall silica inorganic nanoparticle INDA for targeted molecular imaging of cancer

Researchers at Memorial Sloan-Kettering Cancer Center's Nanotechnology Center, along with collaborators at Cornell University and Hybrid Silica Technologies, have received approval for their first Investigational New Drug Application from the US Food and Drug Administration for an ultrasmall silica inorganic nanoparticle platform for targeted molecular imaging of cancer, which may be useful for cancer treatment in the future.

31 Jan 2011

Scientists to commence new DNA vaccine trial for use in patients with leukemia

A new cancer treatment which strengthens a patient's immune system and enables them to fight the disease more effectively is being trialled on patients for the first time in the UK. The treatment will use a new DNA vaccine, developed by scientists from the University of Southampton, which will treat a selected group of volunteers who have either chronic or acute myeloid leukaemia - two forms of bone marrow and blood cancer.

31 Jan 2011

Taxol reduces cell regeneration obstacles after spinal cord injury: Scientists

After a spinal cord injury a number of factors impede the regeneration of nerve cells. Two of the most important of these factors are the destabilization of the cytoskeleton and the development of scar tissue.

29 Jan 2011

Survey finds public lack knowledge of radiotherapy

Fewer than one in ten people think radiotherapy is a modern cancer treatment according to the results of a survey published Friday.

28 Jan 2011

Cancer Therapy News and Research

Breakthrough in cancer research can help reduce heart failure, increase survival rates

NYBC ends emergency appeal for blood donations

CeNeRx announces FDA approval of CXB909 IND for neuroprotection and neurodegenerative disorders

Men with high levels of CCP genes more likely to have fatal form of prostate cancer

Tower announces formation of Cancer Support Network to provide high quality of care

Genomic study identifies link between Native American ancestry, relapse in young leukemia patients

Patients receiving cancer treatment may experience skin, hair, nail problems

EpiCareSRT, Sensus Healthcare aim for mobile non-surgical skin cancer treatment service

Surrogate questions imaging can answer about cancer

PanCare Childhood and Adolescent Cancer Survivor Care and Follow-up Studies to kick off in Lund, Sweden

Losartan improves effectiveness of nanotherapeutics against cancer

Four-gene/protein signature more accurately predicts metastatic prostate cancer

Aphios enters subcontract with SAIC-Frederick to develop phospholipid nanoencapsulated camptothecin

Researchers find breast cancer therapy contributes to early-in-life hip fractures in women

New robotic technique can better predict tumors during radiotherapy, prevent severity of side effects

Fox Chase announces posting of clinical outcomes data to its website for patient use

FDA approves ultrasmall silica inorganic nanoparticle INDA for targeted molecular imaging of cancer

Scientists to commence new DNA vaccine trial for use in patients with leukemia

Taxol reduces cell regeneration obstacles after spinal cord injury: Scientists

Survey finds public lack knowledge of radiotherapy

Your guide to microplate readers for cancer research eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News